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Abstract
Background: Otitis media (OM) is the most common paediatric illness for which antibiotics are
prescribed. In Australian Aboriginal children OM is frequently asymptomatic and starts at a younger
age, is more common and more likely to result in hearing loss than in non-Aboriginal children.
Absent transient evoked otoacoustic emissions (TEOAEs) may predict subsequent risk of OM.
Methods:  100 Aboriginal and 180 non-Aboriginal children in a semi-arid zone of Western
Australia were followed regularly from birth to age 2 years. Tympanometry was conducted at
routine field follow-up from age 3 months. Routine clinical examination by an ENT specialist was
to be done 3 times and hearing assessment by an audiologist twice. TEOAEs were measured at ages
<1 and 1–2 months. Cox proportional hazards model was used to investigate the association
between absent TEOAEs and subsequent risk of OM.
Results: At routine ENT specialist clinics, OM was detected in 55% of 184 examinations in
Aboriginal children and 26% of 392 examinations in non-Aboriginal children; peak prevalence was
72% at age 5–9 months in Aboriginal children and 40% at 10–14 months in non-Aboriginal children.
Moderate-severe hearing loss was present in 32% of 47 Aboriginal children and 7% of 120 non-
Aboriginal children aged 12 months or more.
TEOAE responses were present in 90% (46/51) of Aboriginal children and 99% (120/121) of non-
Aboriginal children aged <1 month and in 62% (21/34) and 93% (108/116), respectively, in
Aboriginal and non-Aboriginal children at age 1–2 months. Aboriginal children who failed TEOAE
at age 1–2 months were 2.6 times more likely to develop OM subsequently than those who passed.
Overall prevalence of type B tympanograms at field follow-up was 50% (n = 78) in Aboriginal
children and 20% (n = 95) in non-Aboriginal children.
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Conclusion: The burden of middle ear disease is high in all children, but particularly in Aboriginal
children, one-third of whom suffer from moderate-severe hearing loss. In view of the frequently
silent nature of OM, every opportunity must be taken to screen for OM. Measurement of TEOAEs
at age 1–2 months to identify children at risk of developing OM should be evaluated in a routine
health service setting.
Background
In industrialised countries otitis media (OM) is the most
common paediatric illness for which medical advice is
sought and antibiotics are prescribed [1]. OM can lead to
impaired hearing, which can seriously affect early lan-
guage development, performance at school, and subse-
quent employment and social integration in adulthood.
Repeated antibiotic treatment for OM contributes to the
increasing levels of antibiotic resistance worldwide [2].
In the general population, OM incidence peaks at age 6–
18 months and 3–17% of children suffer ≥ 3 attacks of
acute OM annually. The prevalence of OM with effusion
(OME) is ~12% at age 1 year [3]. In Western Australia
(WA), OM is the second most common reason for paedi-
atric hospital admission [4]. There are no population-
based data on the burden of OM in the general popula-
tion of Australia other than a nationwide study conducted
30 years ago [5].
Aboriginal Australians are the most disadvantaged sector
of Australian society [6]. The enormous burden of OM in
Australian Aboriginal children contributes to lifelong
social disadvantage. Compared with non-Aboriginal chil-
dren, OM in Aboriginal children is more common, starts
at a younger age, is more likely to result in hearing loss
and is associated with early onset of upper respiratory
tract bacterial carriage [7-11]. The disease may be asymp-
tomatic until purulent ear discharge is visible [8] and so
treatment may not be sought until late in the disease proc-
ess [12]. A recent study in remote communities in the
Northern Territory (NT) of Australia showed that 91% of
Aboriginal children aged 6–30 months had current clini-
cal signs of OM and that tympanic membrane (TM) per-
foration rates varied between communities from 0% to
60% [11]. Data on the burden of OM in young Aboriginal
children living in urban areas are sparse [5,13]. Despite
the enormous burden of disease, there is currently no rou-
tine screening for ear health in preschool-age children in
Western Australia. Thus, many Aboriginal children reach
school age having had recurrent or continuous ear infec-
tions with serious consequences, in particular hearing loss
and impaired language development. This results in poor
educational attainment and behavioural problems, per-
petuating the cycle of ill health, poverty and social exclu-
sion faced by many Aboriginal people. In view of the early
onset of disease which is frequently asymptomatic in Abo-
riginal children, we need appropriate methods of identify-
ing children at high risk of OM in early infancy. Clinical
diagnosis of OM in young children is difficult. Therefore
a simple affordable tool that can be used at the primary
health care level is needed to identify those in need of
prompt treatment to avoid the serious consequences of
tympanic membrane perforation and hearing loss.
Tympanometry is a standard method used to detect mid-
dle ear effusion and OM. Impedance audiometry (tympa-
nometry) is normally conducted using a 226 Hz probe
and is effective in people over the age of 6 months [14,15].
Before age 6 months, a 1000 Hz probe tone improves sen-
sitivity of the test and a screening instrument with 1000
Hz probe tone has recently become available.
Measurement of otoacoustic emissions (OAEs) offers an
alternative to high-frequency tympanometry to assess
middle ear function in early infancy [16]. OAEs originat-
ing in the cochlea are low-level sounds in response to a
given stimulus and can be measured in the outer ear. Tran-
sient evoked OAEs (TEOAEs) are used widely to identify
sensorineural hearing loss in neonates, but OAEs may be
absent as a result of fluid in the middle ear of young
infants [17-19]. Furthermore, absent OAEs in young chil-
dren may identify children at risk of OM in the future
[20]. However, a recent cohort study of American Indian
children followed from birth to age 2 years found no asso-
ciation between absent OAEs in the first month of life and
subsequent risk of OM [21]. There are no other data on
OAEs for indigenous populations and to our knowledge
no studies have investigated the association between pres-
ence or absence of TEOAEs in early infancy after the neo-
natal period (without the use of other assessments of
middle ear disease such as otoscopy) and subsequent risk
of OM. Measurement of OAEs in the postneonatal period
may offer a simple tool for use by primary health care
workers to identify a high-risk group of children.
Between 1999 and 2005, we undertook a study in the Kal-
goorlie-Boulder area of WA, a semi-arid region approxi-
mately 600 km east of the state capital, Perth, to
investigate the causal pathways to OM in Aboriginal and
non-Aboriginal children. The study aimed to identify the
most important, avoidable risk factors in order to develop
appropriate interventions [22]. As expected, we found
that, compared to non-Aboriginal participants, AboriginalBMC Pediatrics 2008, 8:32 http://www.biomedcentral.com/1471-2431/8/32
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mothers were younger, smoked more and had poorer edu-
cational outcomes, mother and fathers were less likely to
be employed and families lived in more crowded condi-
tions [22]. In this paper we report for the first time the
burden of OM in Aboriginal as well as non-Aboriginal
children aged <2 years in such a setting and assess the use
of TEOAEs in the first three months of life in predicting
subsequent risk of OM before age 2 years.
Methods
Details of the methods used in the study, socioeconomic
and demographic characteristics and the completeness of
follow-up are described elsewhere [22]. Briefly, between
April 1999 and January 2003, children born in Kalgoorlie
Regional Hospital to mothers intending to stay in the area
for at least 2 years were recruited into the study. Following
informed consent from mothers, 100 Aboriginal and 180
non-Aboriginal babies were enrolled. Multiple births,
children with severe congenital abnormalities or those
whose birthweight was <2000 g were not eligible. An ini-
tial evaluation was conducted in the home 1–3 weeks
postpartum. Subsequently children were to be seen at ages
6–8 weeks, 4, 6, 12, 18 and 24 months.
Assessment of ear health
Ear health was assessed by a variety of methods at differ-
ent ages: measurement of TEOAEs in children aged <3
months, tympanometry from age 3 months onwards, clin-
ical examination on at least 3 occasions before age 2 years,
and assessment of hearing from age 6 months onwards.
Transient Evoked Otoacoustic Emissions (TEOAEs)
From April 2000 onwards, following training by the sen-
ior audiologist (SW), research assistants (RAs) measured
TEOAEs in quiet surroundings during the scheduled visits
at ages 1–3 and 6–8 weeks using an Echocheck TEOAE
hand-held screener (Otodynamics, Hatfield, UK) [14,23].
Results of the test required no interpretation and were
recorded as pass, fail or not valid, the last usually due to
excessive environmental or subject noise. Valid TEOAE
measurements on each ear were included when investigat-
ing the association between TEOAE and subsequent risk
of OM. However, to determine the prevalence of failed
TEOAEs, if the TEOAE was not valid in one ear the overall
TEOAE assessment for a child was documented as not
valid. Babies who had two consecutive failed TEOAE
responses were referred to an audiologist.
Specialist clinical examination
ENT/audiology clinics were held 4 times annually in the
Audiology Department of the Kalgoorlie Regional Hospi-
tal for routine examination of study participants. Children
were to have a clinical examination at least once at ages
<6, 6–11 and 12–23 months. During the first year of the
study, children were to be assessed more frequently by the
resident audiologist (KM) during field follow-up visits,
but subsequently there was no audiologist permanently
resident in Kalgoorlie. We asked parents and guardians
whether the child had a cold or had any current ear prob-
lems. For convenience, children were occasionally seen by
an ENT specialist (FL) at clinics held every 2–3 months at
Bega Garnbirringu Aboriginal Health Services Aboriginal
Corporation (BEGA).
The ENT specialists established a clinical diagnosis using
otoscopy, pneumatic otoscopy and tympanometry. Diag-
nosis was based on national clinical guidelines [24] and
classified as normal, eustachian tube dysfunction, OME,
AOM without perforation, AOM with perforation, dry
perforation, perforation with purulent discharge, or
unknown when complete examination was not possible
(e.g. unable to visualise TM). It was not possible to make
a diagnosis of chronic suppurative OM given the extended
time intervals between clinical examinations. The final
overall clinical diagnosis was based on the child's most
severely affected ear. If a diagnosis could not be made for
one ear (e.g. due to presence of wax), then the final diag-
nosis was based on the diagnosis for the other ear. How-
ever, to examine the association between failed TEOAEs
and subsequent risk of OM, we included all available
diagnoses on each ear.
Children were followed up, treated or referred by the ENT
specialist or audiologist as required. Routine and review
visits were clearly differentiated on the database. Here we
present only results of routine clinical examinations. But,
when reporting on the number of children who had TM
perforations, we have included additional information
obtained from local medical practitioners, with parental
consent obtained to access their medical records [22].
Tympanometry
Tympanometry with the 226 Hz probe tone is generally
not recommended before age 6 months since a compliant
ear canal may result in lower sensitivity of the test. How-
ever, good specificity and positive or negative predictive
values have been reported in young children [25]. In view
of irregular examinations of young children by a medical
specialist, we did tympanometry from age 3 months dur-
ing routine clinic and field visits to obtain an estimate of
burden of OM in young infants, acknowledging that prev-
alence rates might, if anything, be underestimated.
Audiologists performed tympanometry (Grayson-Stadler
GSI 38, Madison, Wisconsin, USA) on ears without dis-
charge at the ENT clinic. Some children did not attend
ENT clinics at all or only infrequently, despite assistance
with transport and attempts to make appointments at the
most convenient time for families. This might have
resulted in a selection bias of those who chose to attendBMC Pediatrics 2008, 8:32 http://www.biomedcentral.com/1471-2431/8/32
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the routine ENT clinics. Therefore, to obtain additional,
possibly less biased, ear health outcomes more frequently
on more children, RAs performed tympanometry, using a
Maico I24 screening tympanometer (Maico Diagnostics,
Eden Prairie, MN, USA), during routine follow-up visits
from May 2000 onwards, following training by an audiol-
ogist (SW). Inter-observer variation, involving two RAs
doing tympanometry sequentially on the same child, was
assessed regularly. All tympanograms were classified by an
ENT specialist (HC) or an audiologist (SW) according to
standard criteria [15,26]. If tympanometry could not be
assessed in one ear, then the classification for tympanom-
etry was based on the result for the other ear.
Hearing assessment
An audiologist performed hearing assessments in children
aged 12–23 months at the routine ENT/audiology clinics.
From March 2002 onwards, hearing was also assessed
when children were aged 6–11 months. Conditioned Ori-
entation Response Audiometry was conducted in a single
wall paediatric test booth. Narrow-band filtered noises at
500, 1000, 2000 and 4000 Hz were presented by a GSI 16
Clinical Audiometer (Grayson-Stadler, Madison, Wiscon-
sin, USA) calibrated to ANSI 1980 standards [15].
Responses were categorised by averaging the four frequen-
cies tested and classified as normal (<= 25 dB HL), mild
hearing loss (26–40 dB HL), moderate loss (41–60 dB
HL), or severe loss (> 60 dB HL).
Analysis
The chi-square test with continuity correction and Fisher's
Exact test were used to compare variables of interest in
terms of TEOAE outcome. Logistic regression, incorporat-
ing Generalised Estimating Equations to account for
repeated measures on individuals, was used to compare
groups for tympanometry and hearing loss outcomes. The
regression models were adjusted for age.
We used the Cox proportional hazards model to investi-
gate progress to OM by computing hazard ratios for
TEOAE failure. Survival times were from date of test to
first subsequent OM diagnosis. The analysis was con-
ducted on data from individual ears and robust standard
errors were used to account for within-person correlation.
Ethical clearance
The study was endorsed by two local Aboriginal organisa-
tions in Kalgoorlie, namely BEGA and Ngunytju Tjitji
Pirni Inc. Ethical approval for the study was given by the
WA Aboriginal Health Information and Ethics Commit-
tee, the Ethics Committee of Princess Margaret Hospital in
Perth, and that of the Kalgoorlie-Boulder Health and Edu-
cation Region.
Results
Transient evoked otoacoustic emissions
180 infants (57 Aboriginal and 123 non-Aboriginal) were
screened at age <1 month and 168 infants (45 Aboriginal
and 123 non-Aboriginal) were screened at 1–2 months.
TEOAE responses were inconclusive for 6 (11%) Aborigi-
nal children and 2 (2%) non-Aboriginal children aged <1
month and 11 (24%) Aboriginal and 7 (6%) non-Aborig-
inal children aged 1–2 months. Excluding children with
non-valid results in one or both ears, TEOAE responses
were present in at least one ear in 90% (46/51) of Aborig-
inal children and 99% (120/121) of non-Aboriginal chil-
dren aged <1 month. Equivalent figures in the 1–2-month
age group were 62% (21/34) and 93% (108/116), respec-
tively. Figure 1 shows the proportion of children in whom
TEOAE responses were detected in both ears. Pass rates
were significantly lower in Aboriginal than non-Aborigi-
nal children (<1 month 82% vs 97% Fishers Exact test p =
0.003; age 1–2 months 56% vs 90%, Yates chi-square =
17.33, p < 0.0001) (Figure 1). No children had sen-
sorineural hearing loss.
Tympanometry
Overall, 37% (n = 57) of 155 tympanometry readings that
RAs conducted on Aboriginal children during routine fol-
low-ups in the field were normal (type A), 50% (n = 78)
had evidence of middle ear effusion (type B) and 13% (n
= 20) had eustachian tube dysfunction (type C) compared
with 62% (n = 296), 20% (n = 95) and 18% (n = 84),
respectively, in 475 tympanometry readings in non-Abo-
riginal children (chi-square = 54.3, 2 df, p < 0.0001).
Proportion of Aboriginal and non-Aboriginal children with  TEOAE responses present in both ears at ages <1 month and  1–2 months Figure 1
Proportion of Aboriginal and non-Aboriginal children with 
TEOAE responses present in both ears at ages <1 month and 
1–2 months.
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There was a significantly higher prevalence of type B tym-
panograms in Aboriginal children than non-Aboriginal
children both when done by RAs in the field (odds ratio
(OR) = 4.35, 95%CI 2.73–6.95) and when done by audi-
ologists at routine ENT clinic examinations (OR = 5.16,
95%CI 3.12–8.52) (Table 1). Type B tympanograms were
recorded more frequently at routine ENT clinics than at
routine follow-ups in the field in both Aboriginal (OR =
1.86, 95%CI 1.22–2.86) and non-Aboriginal (OR = 1.47,
95%CI 1.06–2.04) children. When we excluded the 21%
of measurements in non-Aboriginal children whose par-
ents reported current symptoms at the routine clinic visit,
the prevalence of type B tympanograms was lower (15%,
26%, 22%, 24% and 25% at ages 3–4, 5–9, 10–14, 15–19
and 20–24 months, respectively) and closer to the field
visit rates shown in Table 1. There was no such reduction
in prevalence of type B tympanograms at routine clinics
when we excluded the 14% of measurements in Aborigi-
nal children who were symptomatic at the routine clinic.
The peak prevalence of type B tympanograms in both field
and clinic was at age 5–9 months in both groups of chil-
dren (Table 1). More than two-thirds of readings in Abo-
riginal children aged 5–19 months attending the routine
follow-up clinic and approximately half in the field were
type B. In non-Aboriginal children the prevalence of type
B tympanograms was 25% between ages 5 and 14 months
on examination in the field and 30% at routine ENT
examination. Type C tympanograms were generally more
common in non-Aboriginal than Aboriginal children
(Table 1).
ENT specialist examinations
Among the 83 Aboriginal clinic attenders 59% were male
and 51% of the 164 non-Aboriginal attenders were male.
Eighty-three percent of Aboriginal children were seen at
least once for routine ENT follow-up and 59% were seen
at least twice. Equivalent figures for non-Aboriginal chil-
dren were 91% and 72%, respectively (Table 2).
On 184 routine clinical examinations in Aboriginal chil-
dren between 8 days and 24 months of age, 55% had signs
of OME, AOM or TM perforation (with or without puru-
lent discharge); 27% of examinations were normal (Table
3). In non-Aboriginal children, 26% of 392 clinical exam-
inations between age 6 days and 23 months had evidence
of OME or AOM and 57% were normal (Table 3). In Abo-
riginal children, the prevalence of OM (i.e. OME, AOM,
and/or perforations) rose from 44% in the first month of
life to 72% at age 5–9 months and remained at 60% or
more; in non-Aboriginal children, prevalence rose to 40%
at age 10–14 months and was still 28% in those aged 20
months or more (Figure 2). Age-specific prevalence rates
of OM were similar when examinations of symptomatic
children were excluded.
A total of 21 (21%) Aboriginal children in the study had
a TM perforation documented at least once during the
study, the earliest being documented in an 8-day-old
child. By the age of 6 months 7% of Aboriginal children
had had a TM perforation at least once (6 of the 85 chil-
dren followed up to age 6 months or more) and 19% (15/
Table 1: Classification of tympanograms in Aboriginal and non-Aboriginal children by age during routine follow-up by research 
assistants in the field or by audiologists at routine ENT follow-up.
Age (months) Tympanogram Aboriginal Non-Aboriginal
Field Clinic Field Clinic
3–4 A 13 (52%) 5 (33%) 65 (77%) 17(68%)
B 11 (44%) 8 (53%) 9 (11%) 5(20%)
C 1 (4%) 2 (13%) 11 (13%) 3(12%)
5–9 A 11(36%) 8(22%) 66 (61%) 47(56%)
B 18 (58%) 26(72%) 30 (27%) 26(31%)
C 2 (6%) 2(6%) 13 (12%) 11(13%)
10–14 A 15 (40%) 7(19%) 63 (54%) 31(49%)
B 18 (49%) 25(69%) 26 (22%) 18(29%)
C 4 (11%) 4(11%) 27 (23%) 14(22%)
15–19 A 11 (39%) 5(22%) 48 (60%) 36(52%)
B 13 (46%) 15(65%) 16 (20%) 21(30%)
C 4 (14%) 3(13%) 16 (20%) 12(17%)
20 + A 7 (21%) 2(20%) 54 (63%) 8(44%)
B 18 (53%) 6(60%) 14 (17%) 5(28%)
C 9 (26%) 2(20%) 17 (20%) 5(28%)BMC Pediatrics 2008, 8:32 http://www.biomedcentral.com/1471-2431/8/32
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80) by the age of 12 months. A perforation was seen in 6
(3%) of the non-Aboriginal children.
ENT specialists recommended insertion of ventilation
tubes (for recurrent AOM and/or persistent OME with
hearing loss and speech concerns) in 12% (n = 12) of
Aboriginal children and 10% (n = 18) of non-Aboriginal
children. This provides a further indication of the burden
of severe middle ear disease.
Hearing assessment
Between 6 and 24 months of age, 61 routine hearing
assessments were performed in Aboriginal children and
169 in non-Aboriginal children. Hearing loss was signifi-
cantly more common in Aboriginal than non-Aboriginal
children (OR = 5.40, 95% CI 2.68–10.89). In Aboriginal
children moderate-severe hearing loss was seen in 39% of
13 assessments done at ages 6–11 months and in 32% of
the 47 assessments in children aged 12 months or more
(Figure 3). In non-Aboriginal children, moderate-severe
hearing loss was detected in 10% of 40 assessments at age
6–11 months and in 7% of 120 assessments at age 12
months or more (Figure 3).
TEOAE responses and subsequent risk of OM
We had valid TEOAE measurements in the first month of
life followed by at least one successful clinical examina-
tion for 102 ears in 54 Aboriginal children and for 234
ears in 120 non-Aboriginal children; at age 1–2 months
there were valid TEOAEs and subsequent clinical exami-
nation on 60 ears in 34 Aboriginal children and on 218
ears in 111 non-Aboriginal children. In Aboriginal chil-
dren, OM was subsequently diagnosed in 55% (n = 46) of
ears for which TEOAE responses were present <1 month of
age compared with 72% (n = 13) of ears with no detecta-
ble TEOAEs at the same age. Equivalent figures for non-
Aboriginal children age <1 month were 31% (n = 70) and
40% (n = 2), respectively. In 1–2-month-old Aboriginal
children, 51% (n = 19) of ears with TEOAE responses
present had a subsequent diagnosis of OM compared with
87% (n = 20) of those with no TEOAE detected. Equiva-
lent figures for non-Aboriginal children were 37% (n =
73) and 32% (n = 6), respectively.
There was a non-significant increased risk of subsequent
OM in all children with failed TEOAE before age 1 month
(Table 4). In contrast, Aboriginal children who failed
TEOAE at age 1–2 months were 2.6 times more likely to
develop OM subsequently than those who passed TEOAE.
Failed TEOAE response did not predict subsequent OM in
Table 2: Number of times children attended ENT/audiology clinic for routine follow-up.
Frequency of routine follow-up at ENT clinic (%)
0123 4 5 6 T o t a l
Aboriginal 17 (17) 24 (24) 34 (34) 14 (14) 6 (6) 4 (4) 1 (1) 100
Non-Aboriginal 16 (9) 35 (19) 64 (36) 42 (23) 15 (8) 5 (3) 3 (2) 180
Total 33 (12) 59 (21) 98 (35) 56 (20) 21 (8) 9 (3) 4 (1) 280
Note: During the first year of study, children were seen by the visiting ENT specialist or by an audiologist who was resident in Kalgoorlie and 
examined children at time of field follow-up. Thereafter, children were to be seen routinely by an ENT 3 times before age 2 years.
Table 3: Clinical diagnosis by ENT specialists at routine follow-
up.
Middle ear diagnosis Aboriginal* Non-Aboriginal*
N% N %
Normal 49 26.6 225 57.4
Eustachian tube dysfunction 17 9.2 37 9.4
Otitis media with effusion 82 44.6 91 23.2
Acute otitis media (AOM) 4 2.2 9 2.3
AOM with TM perforation 9 4.9 2 .5
TM perforation ± discharge** 6 3.3 - -
Other 2 1.1 3 .8
Unknown 15 8.2 25 6.4
Total 184 100.0 392 100.0
* 11% and 8% of diagnoses in Aboriginal and non-Aboriginal children, 
respectively, were based on successful examination of one ear only.
** 2 had dry TM perforation
Age-specific prevalence of OM in Aboriginal and non-Aborig- inal children on routine examination by ENT specialist Figure 2
Age-specific prevalence of OM in Aboriginal and non-Aborig-
inal children on routine examination by ENT specialist.
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non-Aboriginal children aged 1–2 months (Table 4).
Results were very similar when examining TEOAEs in
early infancy and subsequent observation of a type B tym-
panogram either on routine field follow-ups or at routine
ENT clinics (data not shown).
Discussion
To our knowledge this is the first comprehensive investi-
gation of middle ear health (which includes hearing
assessment) conducted simultaneously in young indige-
nous and non-indigenous children living in an urban set-
ting, although an Australia-wide study of Aboriginal and
non-Aboriginal people of all ages was conducted 30 years
ago [5]. All study participants had high rates of OM but
rates were particularly high in Aboriginal children, in
whom disease began at a very young age, as has been
reported previously [7,9,10]. There was significant hear-
ing loss from age 6 months onwards, particularly in Abo-
riginal children, one-third of whom had hearing loss >40
dB. The general lack of symptoms with such high disease
burden is of concern since families would not be
prompted to bring children for medical care.
Aboriginal children were more likely to fail TEOAE meas-
urements than non-Aboriginal children in the first 3
months of life, which is consistent with the earlier onset
of OM in Aboriginal children. Of particular interest was
the finding that absent TEOAEs in Aboriginal children at
age 1–2 months predicted subsequent risk of OM. Not
surprisingly, such an association was not seen in non-
Aboriginal children, given their high pass rate and later
onset of disease.
Comparison with other studies
Prevalence The burden of OM and age-specific prevalence
in non-Aboriginal children is comparable to that found in
studies undertaken elsewhere [1,27,28]. In Aboriginal
children, the age-specific prevalence of OM, and specifi-
cally the prevalence of TM perforations, in this urban/per-
iurban semi-arid area of WA is lower than in many
communities in the NT and WA, though prevalence of dis-
ease varies widely between communities [11,29,30]. The
lower prevalence of OM in the Kalgoorlie-Boulder region
of WA compared with that reported in many NT Aborigi-
nal communities is consistent with lower bacterial car-
riage rates [9,31]. One cannot exclude the possibility that
selection bias may have contributed to the lower rates of
disease in our study, i.e. that parents of a healthier group
of children chose to participate in our study.
While there are no directly comparable data in WA, the
degree of hearing impairment in Aboriginal children in
our study is consistent with that reported among children
aged <5 years in three Aboriginal communities in 1988–
89, where the prevalence of hearing loss ranged between
38% and 63% [29], suggesting that there has been little
improvement in ear health in the past 20 years.
In a state-wide population-based study of Aboriginal chil-
dren in WA 25% of children aged <3 years living in areas
of moderate isolation (such as the Kalgoorlie-Boulder
region) had a history of ear discharge [13], consistent with
our finding that 21% of Aboriginal children had one or
more perforations by age 2 years. It is interesting, how-
ever, to note that 12% of Aboriginal children in our study
were referred for insertion of ventilation tubes. This sug-
gests that, in urban areas at least, closed ear disease (as
Prevalence of moderate-severe and mild hearing loss in Abo- riginal and non-Aboriginal children aged 6–11 and 12–24  months of age Figure 3
Prevalence of moderate-severe and mild hearing loss in Abo-
riginal and non-Aboriginal children aged 6–11 and 12–24 
months of age.
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Table 4: Hazard ratios (and 95% confidence intervals) of OM among Aboriginal and non-Aboriginal children with no detectable 
TEAOE response, compared with those with a TEOAE response, at ages <1 month and 1–<3 months
Age Aboriginal Non-Aboriginal
Hazard ratio 95% CI Hazard ratio 95% CI
<1 month 1.19 (0.66 – 2.16) 2.51 (0.38 – 16.48)
1–<3 months 2.64* (1.32 – 5.31) 0.71 (0.24 – 2.11)
* p = 0.006BMC Pediatrics 2008, 8:32 http://www.biomedcentral.com/1471-2431/8/32
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opposed to perforated ear drums) may now be more com-
mon than in the past.
Hunter et al conducted a cohort study among American
Indians using a similar design to ours, with regular follow-
up of 366 children from birth to age 2 years [21]. The
prevalence of OM by examination of individual ears was
lower (14%, 31%, 47% and 33% in children aged <2, 2–
5, 6–12 and 13–24 months, respectively) than in our Abo-
riginal study population. In the same study, excluding
examinations with technical failures, the failure rate of
distortion product OAEs (DPOAEs) in American Indian
children was of the same order as the TEOAE failure rate
in Aboriginal children in our study: 25% at age <2 months
and 41% at age 2–5 months compared with 18% < 1
month and 44% age 1–<3 months in Aboriginal children
in our study.
Otoacoustic emissions
The pass rate for TEOAEs of 97% among non-Aboriginal
children in our study is consistent with the pass rate of a
newborn hearing screening in Perth, WA, in which the
pass rate was 99% following assessment soon after birth
and a repeat test if the baby failed the first time [23]. To
our knowledge there are no published studies that have
measured OAEs with comparable study design in healthy
young non-indigenous children after the early neonatal
period.
Our TEOAE measurements in Aboriginal children were
inconclusive in 11% of children aged <1 month. This is
higher than the reported 5% technical failure rate in
American Indian children aged <2 months [21], but the
difference is not statistically significant. In older Aborigi-
nal children the proportion of TEOAE tests that were
inconclusive was 24%, similar to a technical fail rate of
27% in American Indian children aged 2–5 months [21].
OAE as predictor Doyle et al [20] followed a small number
of children with and without middle ear effusion (MEE)
at birth. Investigators performed otoscopy in addition to
TEOAE measurement and found that early onset of MEE
predicted subsequent OME and hearing loss in the first
year of life [20]. The only known published study in an
indigenous population reported no association between
failed TEOAE measurements in newborn American Indi-
ans and risk of recurrent OM before age 2 years [21],
though the outcome measures differed between the two
studies ('recurrent OM' as opposed to time to first diagno-
sis of OM in our study). We also found no association
between failed TEOAE in the first month of life and sub-
sequent risk of OM, but such an association was present
for TEOAE measurements after the neonatal period. To
determine whether our findings can be generalised to
other indigenous populations, the use of TEOAE measure-
ments as a predictor should be evaluated in other settings.
Strengths and limitations of the study
The strength of our study is that it provides new informa-
tion on the burden of OM, including impaired hearing
beyond the first year of life and detection of TEOAEs in
indigenous and non-indigenous children living in the
same region. Furthermore, it is the first study in Australia
to investigate TEOAE as a predictor of subsequent disease.
The activities around this study also raised awareness
about OM and the ENT specialist provided expertise not
only to study participants but to others as requested at a
time when limited ENT services were available in Kalgoor-
lie [22].
The principal aim of our cohort study was to investigate
microbiological, immunological, demographic and socio-
economic factors predisposing to OM. In view of the infre-
quent assessments of middle ear status, we were unable to
follow the natural history of the disease and determine
whether the hearing loss and presence of middle ear effu-
sions were continuous or intermittent, as has been
described elsewhere [32].
Data are limited for some outcomes. In particular a lim-
ited number of Aboriginal children were seen by the ENT
specialist on all 3 intended visits. However, tympanome-
try during routine field follow-up provided important
supplementary information on middle ear health and
confirms the enormous burden of disease, particularly in
Aboriginal children. Associations between failed TEOAEs
and presence of type B tympanograms were consistent
between field and clinic follow-up measurements.
Recommendations for surveillance
Given the high prevalence of asymptomatic OM, particu-
larly in Aboriginal children, regular surveillance for ear
disease and hearing loss must be rigidly applied. This
implies first and foremost strong financial support for pri-
mary health care, as well as training and supervision of
primary health care staff.
An optimal screening program in infants should include
newborn hearing screening, followed by otoacoustic
emission testing or high-frequency tympanometry at age
1–2 months to identify children at increased risk of subse-
quent OM, and then audiometry and tympanometry
(with 226 Hz probe tone) between the ages of 6 and 12
months. Services need to be available so that children can
be referred according to national guidelines [24]. Aborig-
inal Health Workers (AHWs), nurses and doctors need to
be encouraged to do otoscopy and/or tympanometry
whenever a child presents with URTI and/or fever or irri-BMC Pediatrics 2008, 8:32 http://www.biomedcentral.com/1471-2431/8/32
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tability in order to initiate treatment at an early stage of
disease [12,24].
Following on from our study, an ear health screening pro-
gram is being introduced in the Goldfields region. The
program includes training of community health nurses
and AHWs in tympanometry, otoscopy and audiometry.
Children are to be assessed at birth, 1–2 months, then 6-
monthly from 6–18 months and annually thereafter to 5
years. Treatment and referral procedures are according to
local standardised protocols based on national guidelines
[24]. This program needs full support and should be for-
mally evaluated. Such an evaluation should consider
detection and referral rates, acceptability of the program
by health service providers and families and changes in
disease rates over a 5-year period as well as an economic
evaluation of the program.
Recommendations for research
1. The role of health professionals (e.g. nurses and AHWs)
with specialist training in ear health should be formally
evaluated as anecdotal evidence suggests that such models
have been successful in identifying and treating children
at Aboriginal Medical Services (Derbarl Yerrigan Aborigi-
nal Medical Service in Perth) and in New Zealand (Variety
Ear Bus Program).
2. Children who participated in our study are now aged 5
– 9 years and of school age. It would be worthwhile iden-
tifying those still in the Kalgoorlie-Boulder region to
determine the long-term outcomes with regard to hearing,
speech, language and education, based on our initial clin-
ical assessments of middle ear health.
3. Measurement of TEOAEs at age 1–2 months to identify
those at risk of developing OM should be evaluated in a
routine health service setting (e.g. through an Aboriginal
Medical Service and/or Ngunytju Tjitji Pirni Inc, a Kalgo-
orlie-based Aboriginal maternal and child health service
provider). This could coincide with the two-month
immunisation visit. Audiological services must, however,
be available for referral of children who fail TEOAE on
two occasions for appropriate management. Such a study
is currently in the planning stage.
4. As part of the ear health program in the Goldfields, we
propose a study comparing performance of TEOAE meas-
urement with that of high-frequency tympanometry at age
1–2 months in predicting risk of subsequent OM. The
study will include an economic component and we will
ask primary health care workers to comment on the prac-
ticality of the different techniques.
5. Given the high rates of OM in the Aboriginal popula-
tion, evaluation of an intervention addressing hygiene
practices to reduce upper respiratory bacterial carriage and
hence OM is urgently needed. This must not deter from
the need to increase availability of appropriate housing to
reduce transmission of respiratory pathogens in crowded
homes.
6. The currently available 7-valent pneumococcal conju-
gate vaccine has not reduced the burden of OM in Aborig-
inal children in NT [33,34]. There is, however, another
conjugate pneumococcal vaccine linked to Haemophilus
influenzae protein D, which has been found to be effica-
cious in preventing episodes of acute OM in Czech Repub-
lic [35] and merits evaluation in the Aboriginal
population. Maternal immunisation with 23-valent pneu-
mococcal polysaccharide vaccine for prevention of OM in
their offspring is currently being evaluated in the NT.
Other protein-based vaccines to prevent OM due to the
pneumococcus, H. influenzae and Moraxella catarrhalis are
under investigation.
Conclusion
In summary we have found high rates of OM in generally
asymptomatic Aboriginal and non-Aboriginal children in
an urban/periurban setting in a semi-arid zone of Aus-
tralia, the rates being particularly high in Aboriginal chil-
dren, though lower than reported in more remote settings.
One-third of Aboriginal children over the age of 6 months
had significant hearing loss. The absence of OAEs after the
neonatal period in Aboriginal children confirms the early
onset of middle ear disease and OAE measurement may
be used to identify children at risk of developing OM.
Given the silent nature of the disease, regular surveillance
for OM and hearing loss must be applied frequently from
a young age. The technology to measure TEOAEs using the
Echocheck is less expensive than the alternative multi-fre-
quency tympanometer in children under the age of 6
months. However, the recent availability of a screening
tympanometer with a 1000 Hz probe tone option may
now make tympanometry a more viable alternative
option as, unlike OAE measurements, it does not require
a quiet environment and settled child. The Echocheck is a
simple screening tool and its use should be evaluated in a
primary health care setting.
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